Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2059

Sep 24, 2018

Call for new approaches to fill significant gaps in understanding Parkinson’s disease

Posted by in category: biotech/medical

New paper calls for the use of advances human-relevant methods to enable understanding of the initiation and progression of Parkinson’s disease.

Read more

Sep 24, 2018

Gene editing wipes out mosquitoes in lab

Posted by in categories: bioengineering, biotech/medical

Researchers have used gene editing to completely eliminate populations of mosquitoes in the lab.

The team tested their technique on the mosquito Anopheles gambiae, which transmits malaria.

They altered part of a gene called doublesex, which determines whether an individual mosquito develops as a male or as a female.

Read more

Sep 24, 2018

The role of brain vasculature in neurodegenerative disorders

Posted by in categories: biotech/medical, neuroscience

Adequate supply of blood and structural and functional integrity of blood vessels are key to normal brain functioning. On the other hand, cerebral blood flow shortfalls and blood–brain barrier dysfunction are early findings in neurodegenerative disorders in humans and animal models. Here we first examine molecular definition of cerebral blood vessels, as well as pathways regulating cerebral blood flow and blood–brain barrier integrity. Then we examine the role of cerebral blood flow and blood–brain barrier in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. We focus on Alzheimer’s disease as a platform of our analysis because more is known about neurovascular dysfunction in this disease than in other neurodegenerative disorders. Finally, we propose a hypothetical model of Alzheimer’s disease biomarkers to include brain vasculature as a factor contributing to the disease onset and progression, and we suggest a common pathway linking brain vascular contributions to neurodegeneration in multiple neurodegenerative disorders.

Read more

Sep 24, 2018

Implant helps paralysed man walk again

Posted by in categories: biotech/medical, neuroscience

Five years after he was paralysed in a snowmobile accident, a man in the US has learned to walk again aided by an electrical implant, in a potential breakthrough for spinal injury sufferers.

A team of doctors at the Mayo Clinic in Minnesota say the man, using a front-wheeled walker, was able to cover the equivalent of the length of a football pitch, issuing commands from his brain to transfer weight and maintain balance—all previously thought impossible for .

Continue reading “Implant helps paralysed man walk again” »

Sep 24, 2018

Known Drug Might Prove Effective Against Alzheimer’s Disease

Posted by in categories: biotech/medical, neuroscience

Apparently, amyloid beta drives its own production in a vicious circle.


In a study at King’s College London, scientists have shown that a vicious circle in which the ill-famed amyloid-beta protein stimulates its own production might be a key factor in the etiology of neurodegeneration in Alzheimer’s disease; furthermore, a drug known as fasudil seems to be effective against amyloid-beta in a mice model of the disease [1].

Study abstract

Continue reading “Known Drug Might Prove Effective Against Alzheimer’s Disease” »

Sep 24, 2018

Asteroids and comets as space weapons

Posted by in categories: asteroid/comet impacts, biotech/medical, existential risks, robotics/AI

A dual use research of concern (DURC) refers to research in the life sciences that, while intended for public benefit, could also be repurposed to cause public harm. One prominent example is that of disease and contagion research (can improve disease control, but can also be used to spread disease more effectively, either accidentally or maliciously). I will argue here that DURC can and should be applicable to any technology that has a potential dual use such as this.


Approximately 66 million years ago, a 10 km sized body struck Earth, and was likely one of the main contributors to the extinction of many species at the time. Bodies the size of 5 km or larger impact Earth on average every 20 million years (one might say we are overdue for one, but then one wouldn’t understand statistics). Asteroids 1 km or larger impact Earth every 500,000 years on average. Smaller bodies which can still do considerable local damage occur much more frequently (10 m wide bodies impact Earth on average every 10 years). It seems reasonable to say that only the first category (~5 km) pose an existential threat, however many others pose major catastrophic threats*.

Given the likelihood of an asteroid impact (I use the word asteroid instead of asteroid and/or comet from here for sake of brevity), some argue that further improving detection and deflection technology are critical. Matheny (2007) estimates that, even if asteroid extinction events are improbable, due to the loss of future human generations if one were to occur, asteroid detection/deflection research and development could save a human life-year for $2.50 (US). Asteroid impact mitigation is not thought to be the most pressing existential threat (e.g. artificial intelligence or global pandemics), and yet it already seems to have better return on investment than the best now-centric human charities (though not non-human charities – I am largely ignoring non-humans here for simplicity and sake of argument).

Continue reading “Asteroids and comets as space weapons” »

Sep 24, 2018

7 Ways Artificial Intelligence is Transforming Healthcare

Posted by in categories: biotech/medical, robotics/AI

From robot doctors to recognising depression.

Read more

Sep 23, 2018

An Eye Infection Found in Contact Lens Wearers Can Cause Blindness

Posted by in category: biotech/medical

Doctors at England’s Moorfields Eye Hospital identified an outbreak of Acanthamoeba keratitis, an eye disease that can cause blindness. This team thinks that the amoeba can travel through the water supply and infect contact wearers who aren’t careful.

Read more

Sep 23, 2018

Study of one million people leads to world’s biggest advance in blood pressure genetics

Posted by in categories: biotech/medical, genetics

Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

Involving more than one million participants, the results more than triple the number of gene regions to over 1,000 and means that almost a third of the estimated heritability for pressure is now explained.

The study, published in Nature Genetics and supported by the National Institute for Health Research (NIHR), Medical Research Council and British Heart Foundation, also reports a strong role of these genes, not only in blood vessels, but also within the adrenal glands above the kidney, and in body fat.

Continue reading “Study of one million people leads to world’s biggest advance in blood pressure genetics” »

Sep 23, 2018

This Study on Nearly Half a Million People Has Bad News For The Keto Diet

Posted by in categories: biotech/medical, food, health

Scientists and dietitians are starting to agree on a recipe for a long, healthy life. It’s not sexy, and it doesn’t involve fancy pills or pricey diet potions.

Fill your plate with plants. Include vegetables, whole grains, healthy fats, and legumes. Don’t include a lot of meat, milk, or highly processed foods that a gardener or farmer wouldn’t recognize.

“There’s absolutely nothing more important for our health than what we eat each and every day,” Sara Seidelmann, a cardiologist and nutrition researcher at Brigham and Women’s Hospital in Boston, told Business Insider.

Continue reading “This Study on Nearly Half a Million People Has Bad News For The Keto Diet” »